The ECR, European Congress of Radiology, came to an end on Sunday 8 March. This year, Guerbet presented its solutions in its 4 growing business segments: MRI, X-ray, Interventional radiology and Medical devices. These 4 days have been rich in meetings, networking and talks about projects with...
01/12/2014 Dotarem : reimbursement in Breast, Brain, Cardiac and Kidney imaging from 2014, 1st December
See new reimbursement forms : FR - NL
16/05/2014 FDA Approves Lipiodol (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known HCC
Read the information
Presented today at the ECR 2014, this unique, innovative solution enables Guerbet to broaden its range in the field of medical equipment and devices for diagnostic imaging market.
26/03/2013 USA : FDA approves Dotarem®
FDA Approves Dotarem® (gadoterate meglumine), first macrocyclic and ionic gadolinium-based contrast agent in USA
22/01/2013 Guerbet at ECR2013
Vienna, Austria Center Vienna, – March 7-11, 2013 (Thursday to Monday) Guerbet will be present at the ECR annual meeting. Come and discover our range of contrast agents and medical devices at our booth #325, Hall C. We also organize a Guerbet Satellite Symposium entitled "Combining high...
11/12/2012 ESUR guidelines contrast media 8.0 : New